Breaking News

Abzena Establishes Scientific Advisory Board to Support Innovation Strategy

The new board will work with Abzena's scientific and commercial leadership to provide strategic guidance and insights.

By: Rachel Klemovitch

Assistant Editor

Abzena, an end-to-end integrated CDMO and CRO for complex biologics and bioconjugates, has announced today the formation of its Scientific Advisory Board (SAB). It is comprised of biopharma industry experts with diversified expertise in Discovery Research & Development (R&D) and Chemistry, Manufacturing, and Controls (CMC).  The new advisory board will work closely with Abzena’s scientific and commercial leadership to provide strategic guidance and expert insights that support A...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters